Lupus
Overview
- Common Renal Problems in Rheumatology
- Ethical Issues in Rheumatology
- Pregnancy in Autoimmune and Musculoskeletal Disease
- Mechanisms of Tissue Injury in Autoimmune Diseases such as Lupus; Autoimmune Disease and Atherosclerosis
- An In-Depth Topic Review of Systemic Lupus Erythematosus
- Medical Management of Arthritis: Early Diagnosis and Current Therapies
- Update on Smallpox and Flu Vaccinations
Pathogenesis
Diagnosis
Therapy/Surgery
- Benlysta (belimumab): A New Lupus Medication on the Horizon
- How do patients respond to support groups such as those at HSS for lupus, rheumatoid arthritis, and myositis? Do patients with mild disease get upset seeing the severe cases?
- A Call to Arms: Treat Rheumatologic Disorders Early and Effectively with Disease-modifying Therapy
- Is there any difference in the prognosis of SLE patients who are diagnosed and treated early versus late in the disease?
- Lower the Thermostat - the Heat is Too High: Winning the Battle and the War
- Our Amazing Progress - and More Within Rheumatology's Grasp
- How long is it necessary to treat active SLE with immunosuppressive drugs? Can immunosuppressive therapy be discontinued? If so, when
Complications & Secondary Illness
- Lupus, Sexuality, and Intimacy: Beginning a Conversation
- Overlap Between Systemic Lupus Erythematosus and Kikuchi Fujimoto Disease
- High-Risk Pregnancy in Lupus Patients
- Steroid-Induced Osteoporosis
- Lupus vs. Preeclampsia
- Progressive Multifocal Leukoencephalopathy (PML) in Two Lupus Patients Treated with Rituximab (Rituxan): An HSS Rheumatology Perspective
- Lupus & Atherosclerosis: Should Recent Findings Alter Our Care of Lupus Patients?
- In patients with lupus and osteoporosis, on prednisone, how would you deal with the osteoporosis when they become pregnant? Would your approach be different if they were not on steroids?
- How should proliferative glomerulonephritis with crescent formation be treated in young women with SLE? Will low-dose pulse cyclophosphamide (Cytoxan) and/or mycophenolate mofetil (CellCept) do the job while preserving fertility?
Research
- Benlysta (belimumab): A New Lupus Medication on the Horizon
- Overlap Between Systemic Lupus Erythematosus and Kikuchi Fujimoto Disease
- Interferon alpha in Lupus and Inflammation in Osteoarthritis - Update from the HSS Immunoregulation Laboratory
- The Use of Disease Registries in the Assessment of Autoimmune Disorders and Cognitive Abnormalities in Patients with Systemic Lupus Erythematosus
- HSS Manual Ch. 5 - Immunogenetic Aspects Of Rheumatic Diseases
Clinical Trials
- A Phase II Randomized Double- Blind, Placebo- Controlled Study to Evaluate the Efficacy and Safety of Rontalizumab (rhuMAb IFNalpha) In Patients with Moderately to Severely Active SLE.
- A Randomized, Double-Blind, Placebo-Controlled, Single Dose-Escalation And Multiple Dose Extension Trial Of NNC 0152-0000-0001 Administered I.V or S.C.. in Subjects with Systemic Lupus Erythematosus
- A Randomized, Double Blind, Placebo Controlled, Multicenter Prospective Dose Finding Phase II/III Study with Atacicept Given Subcutaneously to Subjects having Recently Experienced a Flare of SLE3
- Autoimmune Disease Registry and Repository
- PROMISSE: Predictors of Pregnancy Outcome: Biomarkers in Anti-Phospholipid Antibody Syndrome (APS) and Systemic Lupus Erythematosus (SLE)
- A Phase 1b Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation study with an open-label extension to evaluate the safety and tolerability of multiple IV doses of Medi-545, a fully Human Anti-interferon-alpha Monoclonal Antibody,
- Fc Receptor Function in Normals and Systemic Lupus Erythematosus (SLE)
- Contact HSS
- Give to HSS
- Maps and Directions
- Notice of Privacy Practices
- Terms of Use
- Joint Commission Notice
- HSS Staff Login
©2009 Hospital for Special Surgery. 535 East 70th Street, New York, NY 10021
